詳細介紹
| 品牌 | absin | 純度 | Greater than 95% as determined by reduci |
|---|---|---|---|
| 貨號 | abs04283 | 規格 | 10ug |
| 供貨周期 | 現貨 | 主要用途 | is produced by our Mammalian expression |
| 應用領域 | 化工,生物產業,農林牧漁,制藥/生物制藥,綜合 |
Recombinant Human TNFRSF8 Protein(C-Fc)
| 產品描述 | |
| 描述 | Recombinant Human TNFRSF8 is produced by our Mammalian expression system and the target gene encoding Phe19-Lys379 is expressed with a Fc tag at the C-terminus. |
| 別名 | CD30蛋白;TNFRSF8蛋白;CD30L Receptor蛋白;Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD30; TNFRSF8 |
| 種屬 | Human |
| 來源 | Human Cells |
| 形態 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mMNaCl, pH7.4. |
| 儲存/保存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 性能 | |
| 序列 | FPQDRPFEDTCHGNPSHYYDKAVRRCCYRCPMGLFPTQQCPQRPTDCRKQCEPDYYLDEADRCTA CVTCSRDDLVEKTPCAWNSSRVCECRPGMFCSTSAVNSCARCFFHSVCPAGMIVKFPGTAQKNTV CEPASPGVSPACASPENCKEPSSGTIPQAKPTPVSPATSSASTMPVRGGTRLAQEAASKLTRAPD SPSSVGRPSSDPGLSPTQPCPEGSGDCRKQCEPDYYLDEAGRCTACVSCSRDDLVEK |
| 標簽 | C-Fc |
| 純度 | Greater than 95% as determined by reducing SDS-PAGE. |
| 內毒素水平 | Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test. |
| 溶解方法 | Always centrifuge tubes before opening. Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100 μg/ml. Dissolve the lyophilized protein in ddH2O. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| 靶標 | |
| 背景說明 | CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family, which regulates proliferation/apoptosis and antibody responses. CD30 is expressed by activated, but not by resting, T and B cells. Aberrant expression of CD30 by mastocytosis mast cells and interaction with its ligand CD30L (CD153) appears to play an important role in the pathogenesis and clinical presentation of systemic mastocytosis. CD30 has been considered as a specific diagnostic biomarker of anaplastic large cell lymphoma (ALCL) and classical Hodgkin lymphoma (cHL). CD30 is also a biomarker used for targeted therapy by an antibody–drug conjugate. |
| Accession | P28908 |
| 研究領域 | |
| 研究領域 | CancerTumor biomarkersReceptors CancerTumor immunologyCD markers ImmunologyCell Type MarkersCDNon-lineage ImmunologyInnate ImmunityCytokinesTNF Superfamily |
產品咨詢
電話
微信掃一掃